How Much Money Can You Make From Selling Your Eggs?

Egg donors in the United States typically receive between $5,000 and $10,000 per donation cycle, a range that reflects guidelines from the American Society for Reproductive Medicine (ASRM). In practice, the amount varies considerably depending on the donor’s background, the agency or clinic involved, and market demand. Some donors in high-demand categories report receiving well above that range, while donors in other countries may receive a fraction of it or nothing beyond reimbursed expenses. The money can sound appealing, but understanding what the process demands of your body, your time, and your emotions is essential before treating it as a financial plan.

The Typical Pay Range in the United States

ASRM guidelines state that compensation for oocyte donors is permissible in the $5,000 to $10,000 range, and that range serves as the practical floor and soft ceiling for most donation cycles at reputable clinics and agencies.¹ An analysis of agency and clinic websites found that egg donor agencies were more likely than IVF clinics to indicate compensation, offer a fee range, and set their minimum above $5,000.² That means the number you actually see depends partly on whether you go through an agency, which tends to advertise higher and more variable pay, or directly through a fertility clinic, which often sticks closer to the ASRM guidelines.

It is worth noting that these figures are for a single donation cycle, not a recurring paycheck. Each cycle involves weeks of preparation, daily hormone injections, multiple clinic visits for blood work and ultrasounds, and a surgical egg retrieval procedure under sedation. From the first screening appointment to the retrieval itself, a cycle can take six to eight weeks of active involvement. When you divide the compensation by the hours spent on appointments, injections, and recovery, the effective hourly rate is lower than it might first appear.

What Pushes Compensation Higher or Lower

While ASRM guidelines discourage paying substantially more than $10,000 per cycle on ethical grounds, the market reality in the United States sometimes diverges from those recommendations. Research on compensation factors identifies four main drivers that agencies and intended parents use when setting pay, summarized as ethnicity, education, employment, and esthetics. Donors from ethnic backgrounds that are underrepresented in egg donation, such as East Asian or Jewish donors, often receive higher offers because demand outstrips supply. Donors with high standardized test scores or degrees from well-known universities also command premiums, as do those with particular physical traits like height or athletic build.³

Repeat donors who have already completed a successful cycle and produced a good number of healthy eggs tend to be offered more for subsequent cycles. Agencies sometimes advertise premiums for donors willing to travel or for those with a proven track record. That said, most fertility organizations recommend limiting how many times a woman donates. The commonly cited guideline is six lifetime cycles, although enforcement is difficult since no centralized national registry tracks individual donors across different agencies.

How Compensation Works in Other Countries

The American model of paying thousands of dollars per cycle is unusual globally. Most countries either ban payment outright, cap it at a modest level, or limit reimbursement to documented expenses. In Britain, the Human Fertilisation and Embryology Authority raised the maximum payment in 2012 to a flat rate of £750 (roughly $1,275 at the time), up from £250 plus expenses. Spain offers a lump sum of about €900 (around $1,225). France permits only reimbursement of travel costs and does not allow any payment beyond that.¹

Israel provides a particularly telling example of how payment levels affect donor supply. When the government initially set the pay rate at NIS 9,000 (about $2,625), the number of women willing to donate was strikingly low. In one reported year, only seven Israeli women donated eggs. The government responded by more than doubling the approved payment to NIS 20,000 (about $5,787) in an effort to encourage more women to come forward.¹ The pattern suggests that the level of compensation is a powerful determinant of how many women choose to donate, which is one reason the U.S. market, with its higher payments, has a comparatively larger donor pool.

In some lower-income countries, the financial dynamics look different still. A study of Indian egg donors found that 72% cited financial need as their primary motivation. Of those, 40% spent the money on their children’s school fees, 28% used it for rent, and 20% used it to repay debts.⁴ Only one donor in the study said she wanted to help a childless couple. This underscores a tension that policymakers worldwide grapple with: when compensation is high enough to meaningfully change a donor’s financial situation, the line between voluntary choice and economic pressure gets blurry.

Egg Sharing as an Alternative Model

Not every egg donation involves a cash payment. In the United Kingdom, a model known as “egg sharing” allows women who need IVF themselves to receive free or heavily subsidized fertility treatment in exchange for donating a portion of their eggs to another patient. The cost of the donor’s own IVF cycle is covered by the recipient or the clinic.⁵ For a woman who needs IVF but cannot afford it, this arrangement can be worth thousands of pounds in treatment costs, even though she receives no cash. It is a different way of thinking about compensation, one that replaces money with access to healthcare.

What the Process Does to Your Body

Egg donation is a medical procedure, not a simple transaction, and the physical toll is the part that compensation is theoretically meant to address. The process requires daily self-administered hormone injections over roughly 10 to 14 days to stimulate the ovaries to produce multiple eggs in a single cycle instead of the usual one. This ovarian stimulation is followed by a minor surgical procedure in which a needle is guided through the vaginal wall under ultrasound to extract the eggs from the ovarian follicles. You are sedated during the retrieval, which typically takes 15 to 30 minutes, and most donors go home the same day.

The most well-known risk is ovarian hyperstimulation syndrome, or OHSS, in which the ovaries overreact to the hormones and swell painfully. A survey-based study of 289 egg donors found that moderate OHSS was the most common outcome, reported by 39% of donors in at least one cycle. About 12% experienced severe OHSS in at least one cycle, and roughly 1.4% experienced critical OHSS.⁶ Looking at it on a per-cycle basis, 45% of cycles resulted in only mild symptoms, 20% had no symptoms at all, and 26% were moderate. Severe symptoms occurred in about 9% of individual cycles.

A large-scale study of over 4,000 donor cycles found that complications related to the retrieval procedure itself occurred in about 0.4% of cases, including internal bleeding, severe pain, and one case of ovarian torsion. About 0.15% of donors required surgical intervention. Moderate to severe OHSS in that dataset occurred in 22 donors, all of whom had received a specific type of hormone trigger known as hCG.⁷ The use of a different triggering agent, called a GnRH agonist, substantially reduces the risk of OHSS, and most clinics have shifted toward that approach in recent years.

Mild symptoms that are not classified as OHSS but still affect your daily life, such as bloating, cramping, mood swings, and fatigue from the hormone injections, are nearly universal. These tend to resolve within a week or two after retrieval, but they are part of what makes the time commitment feel heavier than it looks on paper.

The Open Question of Long-Term Health Risks

Short-term risks are relatively well documented, but long-term follow-up studies of egg donors are largely absent. Researchers have flagged this gap repeatedly. One commentary noted that the lack of long-term data should not be mistaken for lack of risk, and described five individual cases of egg donors who developed breast cancer, four of them in their thirties, despite having negative genetic test results.⁸ Five cases cannot establish causation, but the authors’ concern is that no one has done the research to confirm or rule out a connection between repeated ovarian stimulation and later cancers. Long-term hormone replacement therapy is a recognized breast cancer risk factor, and the hormones used in egg donation are potent, so the theoretical concern is not far-fetched.

This is one area where the evidence is genuinely thin, and it matters for anyone thinking about donating more than once. A single cycle exposes you to a brief burst of fertility drugs, but six cycles over several years represents a cumulative hormonal load that no large-scale study has tracked over decades. You will not find a reliable number telling you how much your breast cancer risk or ovarian cancer risk changes, because the study has not been done. Agencies that present egg donation as carrying “no known long-term risks” are technically correct, but the phrasing obscures the reason there are no known risks: no one has looked hard enough.

What Donors Say They Wish They Had Known

An important gap exists between what donors are told during the consent process and what they feel informed about afterward. A survey of egg donors found that while about two-thirds felt their overall experience matched their expectations, only about 45% felt well informed about potential long-term risks. Most felt adequately informed about short-term risks, but the long-term side was poorly communicated.⁹ This aligns with the separate finding that agencies were less likely than IVF clinics to acknowledge a possible cancer risk on their websites.²

On the other hand, a study that used a formal comprehension tool found that egg donors generally demonstrated adequate understanding of both the process and the risks. The researchers noted that physician counseling efforts significantly improved donor comprehension.¹⁰ So the quality of informed consent appears to vary widely depending on where you donate and who walks you through the process. If the clinic or agency rushes through the medical briefing or focuses primarily on logistics and pay, you may not hear enough about what could go wrong beyond the immediate cycle.

The Emotional Side of Donation

Money is the practical motivator for most donors, but egg donation is not psychologically neutral. A survey of donors after they completed the process found that the majority reported positive thoughts and feelings about their donation and about the knowledge that children had been born from their eggs. Negative comments were in the minority but tended to focus on aspects of the process or outcome that the donor had not expected.¹¹ The same study also reported a high prevalence of psychiatric symptoms or diagnoses post-donation among respondents, though the study design makes it hard to know whether those symptoms were caused by the donation experience, preexisted, or would have occurred regardless.

Some donors describe an unexpected emotional weight that comes years later, when they think about the biological children they helped create but will never know. Others report feeling proud that they helped someone become a parent. Anonymous donation was the norm for decades, but the rise of consumer genetic testing has made true anonymity increasingly difficult to maintain. A donor-conceived person can submit a DNA sample to a commercial testing company and potentially identify their biological donor, regardless of any anonymity agreement signed at the time of donation. If you donate eggs today, you should assume that any resulting children may one day be able to find you.

Tax Implications and Hidden Costs

One frequently overlooked detail is that egg donation compensation is taxable income in the United States. Agencies may or may not issue a 1099 form, but the IRS considers the payment taxable regardless. If you receive $8,000 for a cycle, your actual take-home after federal and state taxes could be notably less, depending on your overall income and tax bracket.

There are also indirect costs to consider. The time you spend at appointments is time away from work, and not all employers are understanding about frequent medical visits that you may prefer to keep private. Some donors report needing a day or two of rest after retrieval, which can mean lost wages if you do not have paid time off. Travel expenses to the clinic may or may not be reimbursed depending on your arrangement. And while complications are uncommon, if you develop OHSS or another issue that requires follow-up care, the question of who pays for that treatment is worth clarifying in your contract before you begin. Reputable programs cover medical costs related to the donation, but you want that in writing.

Who Qualifies and Who Gets Screened Out

Becoming an egg donor is not as simple as signing up and showing up. Clinics and agencies screen applicants extensively, and most women who apply are ultimately rejected. Typical eligibility criteria include being between 21 and 34 years old, having a healthy body mass index, being a non-smoker, having no significant family history of genetic disease, and passing psychological screening. You will undergo blood tests for infectious diseases, genetic carrier screening, a pelvic ultrasound to assess ovarian reserve, and a psychological evaluation.

The screening process itself takes time and is unpaid. You might spend several weeks completing applications, attending appointments, and waiting for results before you find out whether you are accepted. If you are rejected at any stage, you receive nothing for that time. Some agencies also require donors to abstain from alcohol, drugs, and sexual intercourse during the stimulation phase, which adds another dimension of personal restriction.

Certain medical conditions or medications disqualify you entirely. If you use hormonal birth control, you may need to stop it before screening. If you have a history of certain psychiatric conditions, some programs will decline your application. The specifics vary by program, but the screening is designed to be rigorous, both to protect the health of the donor and to maximize the chances of a successful outcome for the intended parents.

Donating More Than Once

Because a single cycle can take six to eight weeks and yields a one-time payment, some women consider donating multiple times to increase their total earnings. The commonly referenced guideline of six lifetime cycles was set partly out of concern for the donor’s health and partly to limit the number of genetic half-siblings born from a single donor. At the upper end of the guideline, six cycles at $8,000 each would yield $48,000 before taxes, spread across what could be two to three years or more.

Repeat donation does carry the cumulative medical considerations described earlier. Each cycle exposes you to another round of ovarian stimulation drugs, and the long-term effects of repeated exposure have not been studied in large populations. The emotional experience can also shift over time. A donor who felt good about her first cycle might feel differently by the fourth, particularly if she starts thinking more about the biological children her eggs may have produced. Some donors choose to stop well before they reach the six-cycle limit.

Financially, repeat donors are often offered higher compensation per cycle than first-time donors, since clinics and intended parents value the reduced uncertainty of working with someone who has a proven track record. But the premium is modest in most cases, and treating egg donation as a primary income source is not realistic given the physical demands, the gaps between cycles needed for recovery, and the finite number of times you can do it.